SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001521536-12-000794
Filing Date
2012-08-17
Accepted
2012-08-17 10:46:34
Documents
9
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 q1100688_10qa-biozone.htm 10-Q/A 553260
2 q1100688_ex31-1.htm EX-31.1 9553
3 q1100688_ex32-1.htm EX-32.1 5268
  Complete submission text file 0001521536-12-000794.txt   2053607

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE bzne-20120331.xml EX-101.INS 247777
5 XBRL SCHEMA FILE bzne-20120331.xsd EX-101.SCH 11761
6 XBRL CALCULATION FILE bzne-20120331_cal.xml EX-101.CAL 30777
7 XBRL DEFINITION FILE bzne-20120331_def.xml EX-101.DEF 8411
8 XBRL LABEL FILE bzne-20120331_lab.xml EX-101.LAB 85442
9 XBRL PRESENTATION FILE bzne-20120331_pre.xml EX-101.PRE 63314
Mailing Address 4400 BISCAYNE BLVD SUITE 850 MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD SUITE 850 MIAMI FL 33137 800-689-0930
BIOZONE PHARMACEUTICALS, INC. (Filer) CIK: 0001412486 (see all company filings)

IRS No.: 205978559 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 333-146182 | Film No.: 121041705
SIC: 2834 Pharmaceutical Preparations